Literature DB >> 8147843

Growth factors as survival factors: regulation of apoptosis.

M K Collins1, G R Perkins, G Rodriguez-Tarduchy, M A Nieto, A López-Rivas.   

Abstract

Apoptosis is now widely recognized as a common form of cell death and represents a mechanism of cell clearance in many physiological situations where deletion of cells is required. Peptide growth factors, initially characterised as stimulators of cell proliferation, have now been shown to inhibit death in many cell types. Deprivation of growth factors leads to the induction of apoptosis, i.e. condensation of chromatin and degradation in oligonucleosome-sized fragments, formation of plasma and nuclear membrane blebs and cell fragmentation into apoptotic bodies which can be taken up by neighbouring cells. Here we discuss the mechanism(s) by which growth factors may inhibit apoptosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8147843     DOI: 10.1002/bies.950160210

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  38 in total

1.  Effects of intestinal resection on enterocyte apoptosis.

Authors:  J S Thompson; B Barent
Journal:  J Gastrointest Surg       Date:  1999 Nov-Dec       Impact factor: 3.452

2.  Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors.

Authors:  Stephan P Persengiev; Laxminarayana R Devireddy; Michael R Green
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

3.  [Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

Authors:  P Herminghaus; G Geerling; D Hartwig; T Wedel; L Dibbelt
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

4.  IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis.

Authors:  T Uchida; M G Myers; M F White
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  An optimised protocol for the production of autologous serum eyedrops.

Authors:  L Liu; D Hartwig; S Harloff; P Herminghaus; T Wedel; G Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

Review 6.  Targeting cancer cell death with a bcl-XS adenovirus.

Authors:  J S Han; G Núñez; M S Wicha; M F Clarke
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor.

Authors:  M H Cortazzo; E S Kassis; K A Sproul; N F Schor
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

8.  Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells.

Authors:  D P Frazier; D Cox; E M Godshalk; P A Schaffer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  IL-33/ST2 axis promotes mast cell survival via BCLXL.

Authors:  Jun-Xia Wang; Shinjiro Kaieda; Sarah Ameri; Nadia Fishgal; Daniel Dwyer; Anthony Dellinger; Christopher L Kepley; Michael F Gurish; Peter A Nigrovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

10.  Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Authors:  Umut Arslan; Emin Özmert; Sibel Demirel; Firdevs Örnek; Figen Şermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.